Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0000950103-22-015137
Filing Date
2022-09-01
Accepted
2022-09-01 17:12:04
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM SC TO-C dp179779_sctoc.htm SC TO-C 25244
2 EXHIBIT 99.1 dp179779_ex9901.htm EX-99.1 36091
3 EXHIBIT 99.2 dp179779_ex9902.htm EX-99.2 14801
4 GRAPHIC image_001.jpg GRAPHIC 1981
5 GRAPHIC image_002.jpg GRAPHIC 3740
6 GRAPHIC image_003.jpg GRAPHIC 23958
7 GRAPHIC image_004.jpg GRAPHIC 20048
8 GRAPHIC image_005.jpg GRAPHIC 29394
9 GRAPHIC image_006.jpg GRAPHIC 19489
  Complete submission text file 0000950103-22-015137.txt   214760
Mailing Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000
Business Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000 4544448888
NOVO NORDISK A S (Filed by) CIK: 0000353278 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Subject) CIK: 0001538927 (see all company filings)

EIN.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-91541 | Film No.: 221221720
SIC: 2836 Biological Products, (No Diagnostic Substances)